Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast

Giuseppe Viale, Marcello Gambacorta, Guido Coggi, Patrizia Dell'Orto, Marina Milani, Claudio Doglioni

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Immunostaining for glial fibrillary acidic protein (GFAP) identifies a minor subpopulation of immunoreactive myoepithelial cells in the normal resting human breast. The GFAP-immunoreactive cells also express a panel of myoepithelial cell markers, including cytokeratin 14 (CK 14), vimentin, smooth-muscle-specific actin isoforms, nerve growth factor receptor (NGFR) and common acute lymphoblastic leukaemia antigen (CALLA). The percentage of GFAP-immunoreactive myoepithelial cells is greatly increased in various neoplastic and non-neoplastic diseases of the breast, being highest in adenomyoepitheliomas. Furthermore, in all the instances of fibroadenoma, phyllodes tumour, epitheliosis and gynaecomastia, a variable number of epithelial cells also acquires immunoreactivity for GFAP, vimentin, CK 14, NGFR and, to a lesser extent, for CALLA. Conversely, GFAP immunoreactivity has never been encountered in the malignant cells of the different types of breast carcinoma. These findings suggest that the expression of GFAP might be a (possibly transient) feature of proliferating epithelial and myoepithelial cells in breast diseases other than carcinomas.

Original languageEnglish
Pages (from-to)339-348
Number of pages10
JournalVirchows Archiv A Pathological Anatomy and Histopathology
Volume418
Issue number4
DOIs
Publication statusPublished - Jul 1991

Fingerprint

Breast Diseases
Glial Fibrillary Acidic Protein
Keratin-14
Nerve Growth Factor Receptor
Neprilysin
Vimentin
Epithelial Cells
Phyllodes Tumor
Fibroadenoma
Smooth Muscle
Actins
Protein Isoforms
Breast
Breast Neoplasms
Carcinoma

Keywords

  • Breast
  • Glial fibrillary acidic protein
  • Intermediate filament co-expression
  • Myoepithelial cells

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Anatomy

Cite this

Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast. / Viale, Giuseppe; Gambacorta, Marcello; Coggi, Guido; Dell'Orto, Patrizia; Milani, Marina; Doglioni, Claudio.

In: Virchows Archiv A Pathological Anatomy and Histopathology, Vol. 418, No. 4, 07.1991, p. 339-348.

Research output: Contribution to journalArticle

@article{6983953247084908a2e4d3114ada1184,
title = "Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast",
abstract = "Immunostaining for glial fibrillary acidic protein (GFAP) identifies a minor subpopulation of immunoreactive myoepithelial cells in the normal resting human breast. The GFAP-immunoreactive cells also express a panel of myoepithelial cell markers, including cytokeratin 14 (CK 14), vimentin, smooth-muscle-specific actin isoforms, nerve growth factor receptor (NGFR) and common acute lymphoblastic leukaemia antigen (CALLA). The percentage of GFAP-immunoreactive myoepithelial cells is greatly increased in various neoplastic and non-neoplastic diseases of the breast, being highest in adenomyoepitheliomas. Furthermore, in all the instances of fibroadenoma, phyllodes tumour, epitheliosis and gynaecomastia, a variable number of epithelial cells also acquires immunoreactivity for GFAP, vimentin, CK 14, NGFR and, to a lesser extent, for CALLA. Conversely, GFAP immunoreactivity has never been encountered in the malignant cells of the different types of breast carcinoma. These findings suggest that the expression of GFAP might be a (possibly transient) feature of proliferating epithelial and myoepithelial cells in breast diseases other than carcinomas.",
keywords = "Breast, Glial fibrillary acidic protein, Intermediate filament co-expression, Myoepithelial cells",
author = "Giuseppe Viale and Marcello Gambacorta and Guido Coggi and Patrizia Dell'Orto and Marina Milani and Claudio Doglioni",
year = "1991",
month = "7",
doi = "10.1007/BF01600164",
language = "English",
volume = "418",
pages = "339--348",
journal = "Virchows Archiv - A Pathological Anatomy and Histopathology",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Glial fibrillary acidic protein immunoreactivity in normal and diseased human breast

AU - Viale, Giuseppe

AU - Gambacorta, Marcello

AU - Coggi, Guido

AU - Dell'Orto, Patrizia

AU - Milani, Marina

AU - Doglioni, Claudio

PY - 1991/7

Y1 - 1991/7

N2 - Immunostaining for glial fibrillary acidic protein (GFAP) identifies a minor subpopulation of immunoreactive myoepithelial cells in the normal resting human breast. The GFAP-immunoreactive cells also express a panel of myoepithelial cell markers, including cytokeratin 14 (CK 14), vimentin, smooth-muscle-specific actin isoforms, nerve growth factor receptor (NGFR) and common acute lymphoblastic leukaemia antigen (CALLA). The percentage of GFAP-immunoreactive myoepithelial cells is greatly increased in various neoplastic and non-neoplastic diseases of the breast, being highest in adenomyoepitheliomas. Furthermore, in all the instances of fibroadenoma, phyllodes tumour, epitheliosis and gynaecomastia, a variable number of epithelial cells also acquires immunoreactivity for GFAP, vimentin, CK 14, NGFR and, to a lesser extent, for CALLA. Conversely, GFAP immunoreactivity has never been encountered in the malignant cells of the different types of breast carcinoma. These findings suggest that the expression of GFAP might be a (possibly transient) feature of proliferating epithelial and myoepithelial cells in breast diseases other than carcinomas.

AB - Immunostaining for glial fibrillary acidic protein (GFAP) identifies a minor subpopulation of immunoreactive myoepithelial cells in the normal resting human breast. The GFAP-immunoreactive cells also express a panel of myoepithelial cell markers, including cytokeratin 14 (CK 14), vimentin, smooth-muscle-specific actin isoforms, nerve growth factor receptor (NGFR) and common acute lymphoblastic leukaemia antigen (CALLA). The percentage of GFAP-immunoreactive myoepithelial cells is greatly increased in various neoplastic and non-neoplastic diseases of the breast, being highest in adenomyoepitheliomas. Furthermore, in all the instances of fibroadenoma, phyllodes tumour, epitheliosis and gynaecomastia, a variable number of epithelial cells also acquires immunoreactivity for GFAP, vimentin, CK 14, NGFR and, to a lesser extent, for CALLA. Conversely, GFAP immunoreactivity has never been encountered in the malignant cells of the different types of breast carcinoma. These findings suggest that the expression of GFAP might be a (possibly transient) feature of proliferating epithelial and myoepithelial cells in breast diseases other than carcinomas.

KW - Breast

KW - Glial fibrillary acidic protein

KW - Intermediate filament co-expression

KW - Myoepithelial cells

UR - http://www.scopus.com/inward/record.url?scp=0025896436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025896436&partnerID=8YFLogxK

U2 - 10.1007/BF01600164

DO - 10.1007/BF01600164

M3 - Article

VL - 418

SP - 339

EP - 348

JO - Virchows Archiv - A Pathological Anatomy and Histopathology

JF - Virchows Archiv - A Pathological Anatomy and Histopathology

SN - 0945-6317

IS - 4

ER -